Novavax Inc
Novavax Inc (NVAX) Option Chain
Read more
Tracking the NVAX option chain helps you see every strike and expiry on Novavax Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of NVAX options activity at a glance. Use our scanner to monitor the NVAX option chain in real time and filter for the trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For NVAX stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where NVAX options are being actively traded, and where they are not.
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics.
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 9.80 | 0 | 0 | 0.61 | 0.97 | 0.01 | 3.15 | 6.50 | -12.99 | — | 0.27 | 0.00 | 0.27 | 2 | 2 | 90.20 |
| 28.08 | 1 | 37 | 0.47 | 0.47 | 0.48 | 1.39 | 7.00 | -6.29 | — | 0.54 | 0.00 | 0.54 | 44 | 33 | 71.92 |
| 53.31 | 17 | 34 | 0.37 | 0.00 | 0.05 | 0.69 | 7.50 | +0.40 | — | 0.89 | 0.03 | 0.86 | 3 | 18 | 46.69 |
| 75.92 | 138 | 24 | 0.18 | 0.00 | 0.05 | 0.31 | 8.00 | +7.09 | 0.19 | 1.05 | 0.53 | 0.09 | 3 | 80 | 24.08 |
| 90.09 | 124 | 35 | 0.05 | 0.00 | 0.01 | 0.09 | 8.50 | +13.79 | 0.69 | 1.51 | 1.03 | 0.07 | 2 | 39 | 9.91 |
As of Nov 20, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV Rank31.94% Moderate
- Market cap (M$)1,233
- 52 weeks high-44.17%
- 52 weeks low19.71%
- Analyst recommendationHold
2.62 - Target price$13.88
85.81% above the current stock price - Dividend—
- Payout ratio0.00%
- Earnings date2026-11-05
- P/E—
- Future P/E—
- EPS (ttm)-0.47
- EPS growth next 5 years—
As of Nov 20, 2026